Possible False-Negative Results on Therapeutic Drug Monitoring of Phenytoin Using a Particle Enhanced Turbidimetric Inhibition Immunoassay in a Patient With a High Level of IgM-Reference-Cited by-同舟云学术

Possible False-Negative Results on Therapeutic Drug Monitoring of Phenytoin Using a Particle Enhanced Turbidimetric Inhibition Immunoassay in a Patient With a High Level of IgM

Published:2014-10 Issue:5 Volume:36 Page:553-555
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Hirata Kenshiro,Saruwatari Junji,Enoki Yuhuki,Iwata Kazufumi,Urata Yukino,Aizawa Keiji,Ueda Kentaro,Shirouzono Takumi,Imamura Motoki,Moriuchi Hiroshi,Ishima Yu,Kadowaki Daisuke,Watanabe Hiroshi,Hirata Sumio,Maruyama Toru,Fukunaga Eiko

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference10 articles.

1. . Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.;Taguchi;Drug Metab Dispos,2009

2. . Developing a nomogram for dose individualization of phenytoin in Asian pediatric patients derived from population pharmacokinetic modeling of saturable pharmacokinetic profiles of the drug.;Lee;Ther Drug Monit,2013

3. PETINIA total phenytoin assay on the vista 1500 analyzer is not suitable for monitoring free phenytoin concentration if ultrafiltration is performed at room temperature.;Dasgupta;Ther Drug Monit,2013

4. . Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.;Patsalos;Epilepsia,2008

5. . Comparison of assay methods used to measure antiepileptic drugs in plasma.;Wilson;Ther Drug Monit,1983

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferences in immunoassays: review and practical algorithm;Clinical Chemistry and Laboratory Medicine (CCLM);2022-03-18

2. Effects of bilirubin, lipemia, hemolysis, paraproteins and heterophilic antibodies on immunoassays for therapeutic drug monitoring;Therapeutic Drug Monitoring Data;2020

3. Issues of Interferences in Therapeutic Drug Monitoring;Biotin and Other Interferences in Immunoassays;2019

4. A Spuriously High Phenytoin Level and an Abnormal Lipemic Index: When Aberrant Laboratory Results Lead to a Medical Diagnosis;The Journal of Applied Laboratory Medicine;2017-05-01

5. When not to trust therapeutic drug monitoring: Table 1:;Oxford Medical Case Reports;2016-09